Page last updated: 2024-11-02

phenindione and Purpura, Thrombotic Thrombocytopenic

phenindione has been researched along with Purpura, Thrombotic Thrombocytopenic in 1 studies

Phenindione: An indandione that has been used as an anticoagulant. Phenindione has actions similar to WARFARIN, but it is now rarely employed because of its higher incidence of severe adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p234)

Purpura, Thrombotic Thrombocytopenic: An acquired, congenital, or familial disorder caused by PLATELET AGGREGATION with THROMBOSIS in terminal arterioles and capillaries. Clinical features include THROMBOCYTOPENIA; HEMOLYTIC ANEMIA; AZOTEMIA; FEVER; and thrombotic microangiopathy. The classical form also includes neurological symptoms and end-organ damage, such as RENAL FAILURE. Mutations in the ADAMTS13 PROTEIN gene have been identified in familial cases.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kincaid-Smith, P1
Saker, BM1
Fairley, KF1

Other Studies

1 other study available for phenindione and Purpura, Thrombotic Thrombocytopenic

ArticleYear
Anticoagulants in "irreversible" acute renal failure.
    Lancet (London, England), 1968, Dec-28, Volume: 2, Issue:7583

    Topics: Acute Kidney Injury; Adolescent; Adult; Anticoagulants; Arteritis; Creatinine; Dipyridamole; Female;

1968